KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xylem (XYL) Revenue (2016 - 2025)

Xylem (XYL) has 15 years of Revenue data on record, last reported at $2.4 billion in Q4 2025.

  • For Q4 2025, Revenue rose 6.25% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, down 44.38%, while the annual FY2025 figure was $9.0 billion, 5.52% up from the prior year.
  • Revenue reached $2.4 billion in Q4 2025 per XYL's latest filing, up from -$6.0 million in the prior quarter.
  • Across five years, Revenue topped out at $2.4 billion in Q4 2025 and bottomed at -$21.0 million in Q1 2021.
  • Average Revenue over 5 years is $848.0 million, with a median of $633.0 million recorded in 2022.
  • Peak YoY movement for Revenue: crashed 101.87% in 2021, then soared 16214.29% in 2024.
  • A 5-year view of Revenue shows it stood at -$21.0 million in 2021, then skyrocketed by 7271.43% to $1.5 billion in 2022, then crashed by 100.93% to -$14.0 million in 2023, then skyrocketed by 16214.29% to $2.3 billion in 2024, then rose by 6.25% to $2.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $2.4 billion in Q4 2025, -$6.0 million in Q3 2025, and -$9.0 million in Q2 2025.